成大生物
(688739)
| 流通市值：52.65亿 | | | 总市值：116.15亿 |
| 流通股本：1.89亿 | | | 总股本：4.16亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,264,317,684.83 | 4,133,700,011.91 | 4,590,885,490.11 | 4,547,961,783.28 |
| 应收票据及应收账款 | 1,193,923,521.43 | 1,193,926,644.1 | 1,101,472,743.09 | 1,082,158,497.94 |
| 应收账款 | 1,193,923,521.43 | 1,193,926,644.1 | 1,101,472,743.09 | 1,082,158,497.94 |
| 预付款项 | 33,505,549.8 | 31,772,432.31 | 34,402,383.56 | 29,784,661.05 |
| 其他应收款合计 | 1,559,575.68 | 1,547,398.68 | 6,169,548.85 | 11,905,992.85 |
| 存货 | 447,853,539.1 | 435,659,834.75 | 455,193,773.93 | 422,423,625.55 |
| 其他流动资产 | 30,853,224.78 | 323,858.33 | 60,505,170.25 | 60,504,640.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,063,829,229.86 | 7,004,743,625.52 | 7,237,358,260.25 | 7,248,921,187.32 |
| 非流动资产: | | | | |
| 长期股权投资 | 104,147,251.69 | 108,470,884.15 | 109,242,395.22 | 110,521,418.31 |
| 其他非流动金融资产 | 95,103,711.08 | 95,103,711.08 | 112,474,551.79 | 114,548,298.88 |
| 固定资产 | 1,508,992,817.6 | 1,519,722,981.69 | 1,434,794,015.48 | 1,425,521,586.35 |
| 在建工程 | 408,674,041.58 | 392,249,634.62 | 437,804,194.99 | 438,823,221.28 |
| 使用权资产 | 16,503,853.02 | 17,729,684.43 | 18,955,515.84 | 20,181,347.25 |
| 无形资产 | 183,271,615.64 | 184,872,159.76 | 177,338,557.25 | 178,872,744.62 |
| 开发支出 | 514,867,903.95 | 459,412,363.55 | 399,743,729.99 | 363,385,650.03 |
| 长期待摊费用 | 14,876,642.87 | 15,911,207 | 16,945,771.13 | 17,980,335.26 |
| 递延所得税资产 | 39,866,835.11 | 37,247,813.34 | 32,696,111.43 | 42,392,273.63 |
| 其他非流动资产 | 83,197,497.1 | 95,930,241.48 | 125,208,579.4 | 120,211,022.26 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,969,502,169.64 | 2,926,650,681.1 | 2,865,203,422.52 | 2,832,437,897.87 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,033,331,399.5 | 9,931,394,306.62 | 10,102,561,682.77 | 10,081,359,085.19 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 258,576,454.34 | 257,092,783.93 | 221,871,119.78 | 215,079,932.78 |
| 应付账款 | 258,576,454.34 | 257,092,783.93 | 221,871,119.78 | 215,079,932.78 |
| 合同负债 | 865,256.29 | 4,739,806.23 | 2,998,987.91 | 1,969,380.18 |
| 应付职工薪酬 | 81,191,721.5 | 71,056,167.08 | 52,596,439.19 | 100,676,182.07 |
| 应交税费 | 32,633,293.61 | 39,994,285.49 | 42,763,808.74 | 33,431,560.62 |
| 其他应付款合计 | 977,800 | 863,800 | 879,906.52 | 763,913.99 |
| 应付股利 | 400,800 | 400,800 | 283,200 | 283,200 |
| 一年内到期的非流动负债 | 5,081,183.11 | 5,023,634.71 | 4,966,870.27 | 4,864,198.91 |
| 其他流动负债 | 1,788.79 | 7,511.04 | 27,360.1 | 660.58 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 379,327,497.64 | 378,777,988.48 | 326,104,492.51 | 356,785,829.13 |
| 非流动负债: | | | | |
| 租赁负债 | 12,217,378.31 | 12,512,721.55 | 14,699,325.72 | 15,141,489.49 |
| 递延收益 | 92,247,773.96 | 94,951,403.45 | 97,718,408.94 | 100,793,903.43 |
| 递延所得税负债 | 184,924.71 | 51,580.46 | 458,283.26 | 9,496,223.38 |
| 其他非流动负债 | 9,300 | 6,200 | 3,100 | 12,400 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 104,659,376.98 | 107,521,905.46 | 112,879,117.92 | 125,444,016.3 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 483,986,874.62 | 486,299,893.94 | 438,983,610.43 | 482,229,845.43 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 416,450,000 | 416,450,000 | 416,450,000 | 416,450,000 |
| 资本公积 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 |
| 减:库存股 | 149,992,850 | 144,758,144.13 | 117,005,156.39 | 99,990,287.88 |
| 盈余公积 | 208,225,000 | 208,225,000 | 208,225,000 | 208,225,000 |
| 未分配利润 | 4,040,488,255.34 | 3,931,003,437.27 | 4,121,734,109.19 | 4,040,270,408.1 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,549,344,524.88 | 9,445,094,412.68 | 9,663,578,072.34 | 9,599,129,239.76 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 9,549,344,524.88 | 9,445,094,412.68 | 9,663,578,072.34 | 9,599,129,239.76 |
| 负债和股东权益合计 | 10,033,331,399.5 | 9,931,394,306.62 | 10,102,561,682.77 | 10,081,359,085.19 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-30 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |